Paradox 发表于 2025-3-30 08:51:22

https://doi.org/10.1007/978-94-011-4643-2cancer; clinical trial; immunosuppression; kidney; transplantation

假装是我 发表于 2025-3-30 12:49:35

http://reply.papertrans.cn/47/4623/462291/462291_52.png

PTCA635 发表于 2025-3-30 19:18:01

Cardiovascular complications after renal transplantation The survival advantage conferred by transplantation is well illustrated by the studies of Port et al. and Bonal et al. . The relative mortality of graft recipients beyond the first month after transplantation was substantially lower, particularly in diabetic patients and high risk elderl

Atheroma 发表于 2025-3-31 00:09:13

http://reply.papertrans.cn/47/4623/462291/462291_54.png

严厉谴责 发表于 2025-3-31 03:49:36

http://reply.papertrans.cn/47/4623/462291/462291_55.png

abject 发表于 2025-3-31 07:25:13

http://reply.papertrans.cn/47/4623/462291/462291_56.png
页: 1 2 3 4 5 [6]
查看完整版本: Titlebook: Immunosuppression under Trial; Proceedings of the 3 P. Cochat,J. Traeger,M. Derchavane Conference proceedings 1999 Springer Science+Busines